Oral pemphigoid autoantibodies preferentially target BP180 ectodomain

Valentina Calabresi, Marco Carrozzo, Emanuele Cozzani, Paolo Arduino, Giorgio Bertolusso, Federico Tirone, Aurora Parodi, Giovanna Zambruno, Giovanni Di Zenzo

Research output: Contribution to journalArticlepeer-review


Mucous membrane pemphigoid (MMP) comprises a heterogenous group of autoimmune subepithelial bullous diseases very frequently having oral involvement. Very few studies have investigated the immunological status of a subset of MMP, termed oral pemphigoid (OP), presenting with exclusive oral lesions. In this study we show that 75% of 20 OP patients without scarring phenotype possessed circulating autoantibodies against the BP180 molecule, indicating a prominent role of this protein as a target antigen in OP. Of note, the frequency of reactivity against BP180 ectodomain epitopes in OP was similar to that previously reported for MMP with cicatricial phenotype, while the lack of significant recognition of BP180 intracellular domain appears to characterize OP with respect to other diseases of the pemphigoid group. Finally, the combined use of sensitive techniques allowed the detection of circulating autoantibodies in 90% of OP patients, supporting the usefulness of this approach in the diagnosis of MMP disease.

Original languageEnglish
Pages (from-to)207-213
Number of pages7
JournalClinical Immunology
Issue number2
Publication statusPublished - Feb 2007


  • Autoantibody
  • BP180
  • Epitope profile
  • Mucous membrane pemphigoid
  • Oral pemphigoid

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy


Dive into the research topics of 'Oral pemphigoid autoantibodies preferentially target BP180 ectodomain'. Together they form a unique fingerprint.

Cite this